Analysis of IL-2, IL-4 and Their Receptors in Clonally-Related Cell Lines Derived from a Patient with a Progressive Cutaneous T-cell Lymphoproliferative Disorder

References

• Paul W. E., Seder R. A. Lymphocyte Responses and cytokines. Cell 1994; 76: 241–251
   PubMed Web of Science ®Google Scholar
• Haanen J. B., De Waal Malefijt R., Res P. C., Kraakman E. M., Ottenhoff T. H., De Vries R. P., Spits H. Selection of a human T helper type 1-like T cell subset by mycobacteria. J. Exp. Med. 1991; 174: 583–592
   PubMed Web of Science ®Google Scholar
• Yssel H., Shanafelt M.-C., Soderberg C., Schneider P. V., Anzola J., Peltz G. Borrelia burgdoferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med. 1991; 174: 593–601
   PubMed Web of Science ®Google Scholar
• Brod S. A., Benjamin D., Hafler D. A. Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease. J. Immunol. 1991; 147: 810–815
   PubMed Web of Science ®Google Scholar
• Kay A. B., Ying S., Varney V., Gaga M., Durham S. R., Moqbel R., Wardlaw A. J., Hamid Q. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late phase cutaneous reactions in atopic subjects. J. Exp. Med. 1991; 173: 775–778
   PubMed Web of Science ®Google Scholar
• Vowels B. R., Cassin M., Vonderheit E. C., Rook A. H. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion resembles murine Th2 cells. J. Invest. Dermatol. 1992; 99: 90–94
   PubMed Web of Science ®Google Scholar
• Dummer R., Kohl O., Gillessen J., Kagi M., Burg G. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Arch. Dermatol. 1993; 129: 433–436
   PubMed Web of Science ®Google Scholar
• Clerici M., Shearer G. M. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 1993; 14: 107–111
   PubMedGoogle Scholar
• Clerici M., Lucey D. R., Berzofsky J. A., Pinto L. A., Wynn T. A., Blatt S. P., Dolan M. J., Hendrix C. W., Wolf S. F., Shearer G. M. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993; 262: 1721–1724
   PubMed Web of Science ®Google Scholar
• Minami Y., Kono T., Miyazaki T., Taniguchi T. The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 1993; 11: 245–268
   PubMed Web of Science ®Google Scholar
• Voss S. D., Hong R., Sondel P. M. Severe combined immunodeficiency, interleukin-2 (IL-2), and IL-2 receptor: experiments of nature continue to point the way. Blood 1994; 83: 626–635
   PubMed Web of Science ®Google Scholar
• Arima N., Kamio M., Imada K., Hori T., Hattori T., Tsudo M., Okuma M., Uchiyama T. Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling. J. Exp. Med. 1992; 176: 1265–1272
   PubMed Web of Science ®Google Scholar
• Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the gamma chain of the human IL-2 receptor. Science 1992; 257: 379–382
   PubMed Web of Science ®Google Scholar
• Asao H., Takeshita T., Ishii N., Kumaki S., Nakamura M., Sugamura K. Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways. Proc. Natl. Acad. Sci. USA 1993; 90: 4127–4131
   PubMed Web of Science ®Google Scholar
• Honda M., Katsuhiko K., Toshikazu T., Sugamura K., Tokunaga T. Identification of a soluble IL-2 receptor beta chain from human lymphoid cell line cells. J. Immun. 1990; 145: 4131–4135
   PubMed Web of Science ®Google Scholar
• Kondo M., Takeshita T., Ishii N., Nakamura M., Watanabe S., Arai K., Sugamura K. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 1993; 262: 1874–1877
   PubMed Web of Science ®Google Scholar
• Russell S. M., Keegan A. D., Harada N., Nakamura Y., Noguchi M., Leland P., Friedmann M. C., Miyajima A., Puri R. K., Paul W. E., Leonard W. J. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 1993; 262: 1880–1883
   PubMed Web of Science ®Google Scholar
• Mosley B., Beckman M. P., March C. J., Izerda R. L., Gimpel S. D., Vanden Bos T., Friend D., Alpert A., Anderson D., Jackson J., Wignall J. M., Smith J. M., Gallis B., Urdal J. E., Widmer M. B., Cosman D., Park L. S. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 1989; 59: 335–348
   PubMed Web of Science ®Google Scholar
• Davis T. H., Morton C. C., Miller-Cassman R., Balk S. P., Kadin M. E. Hodgkin's disease, Lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N. Engl. J. Med. 1992; 326: 1115–1122
   PubMed Web of Science ®Google Scholar
• Su I. J., Balk S. P., Kadin M. E. Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies. Am. J. Pathol. 1988; 132: 192–198
   PubMed Web of Science ®Google Scholar
• Hamano T., Jin Kim K., Leiserson W. L., Asofsky R. Establishment of B cell hybridomas with B cell surface antigens. J. Immunol. 1982; 129: 1403–1409
   PubMed Web of Science ®Google Scholar
• Kawasaki E. S. Amplification of RNA. PCR protocols, a guide to methods and applications, M. A. Innis, D. H. Gelfand, J. J. Sninsky, T. J. White. Academic Press, Inc., San Diego, CA 1990; 21
   Google Scholar
• Ehlers S., Smith K. A. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J. Exp. Med. 1991; 173: 25–36
   PubMed Web of Science ®Google Scholar
• Cartun R. W., Pedersen C. A. An immunocytochemical technique offering increased sensitivity and lowered cost with a streptavidin-horseradish peroxidase conjugate. J. Histotechnol. 1989; 12: 273–279
   Web of Science ®Google Scholar
• Wasik M. A., Sioutos N., Tuttle M., Butmarc J. R., Kadin M. E. Constitutive secretion of soluble IL-2 receptor by human T-cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble IL-2R in body fluids of the host mice. Am. J. Path. 1994; 144: 1089–1097
   PubMed Web of Science ®Google Scholar
• Seldin D. C., Leder P. The human IL4 receptor shares a critical signal transduction domain with other cytokine receptors. J. Cell Biochem. 1992, supp 16c: 90
   Google Scholar
• Scudiero D. A., Shoemaker R. H., Paull K. D., Monks A., Tierney S., Nofziger T. H., Currens M. J., Seniff D., Boyd M. R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Research 1988; 48: 4827–4833
   PubMed Web of Science ®Google Scholar
• Wasik M. A., Muirhead D., Rubocki R., Milgrom F. Enzyme immunoassay with cell suspensions; studies on reactions between serum antibodies and cell-surface antigens. Int. Archs. Allergy Appl. Immun. 1986; 81: 269–275
   PubMedGoogle Scholar
• Morrison B. W., Leder P. A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. J. Biol. Chem. 1992; 267: 11957–11963
   PubMed Web of Science ®Google Scholar
• Flanagan J. G., Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 1990; 63: 185–194
   PubMed Web of Science ®Google Scholar
• Wasik M. A., Morimoto C. Differential effects of cytokines on proliferative response of human CD4+ T cell subsets stimulated via CD3-TCR complex. J. Immunol. 1990; 144: 3334–3340
   PubMed Web of Science ®Google Scholar
• Wasik M. A. Preferential interaction of the CD4+29+/45RA- subset of human CD4+ T lymphocytes with an antibody against the cell membrane ganglioside GD3. Scand. J. Immunol. 1992; 35: 421–428
   PubMed Web of Science ®Google Scholar
• Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 1991; 5: 2567–2574
   PubMed Web of Science ®Google Scholar
• Noma T., Nakakubo H., Sugita M., Kumaga S., Maeda M., Shimizu A., Honjo T. Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related. J. Exp. Med. 1989; 169: 1853–1858
   PubMed Web of Science ®Google Scholar
• Fliedner A., Orscheschek K., Sebald W., Mueller-Hermelink H. K., Feller A. C. Cytokine expression in T-cell lymphomas and Hodgkin's disease: Its possible implication in autocrine or paracrine production as potential basis for neoplastic growth. Am. J. Pathol. 1991; 139: 1173–1180
   PubMed Web of Science ®Google Scholar
• Peuchmaur M., Emilie D., Crevon M. C., Solal-Celigny P., Maillot M. C., Lemaigre G., Galanaud P. IL-2 mRNA expression in Tac-positive malignant lymphomas. Am. J. Pathol. 1990; 136: 383–390
   PubMed Web of Science ®Google Scholar
• Carbonnel F., Lavergne A., Messing B., Tsapis A., Berger R., Galian A., Nemeth J., Brouet J. C., Rambaud J. C. Extensive small intestinal T-cell lymphoma of low-grade malignancy associated with new chromosomal translocation. Cancer 1994; 73: 1286–1291
   PubMed Web of Science ®Google Scholar
• Tesch H., Gunther A., Abts H., Jucker M., Klein S., Krueger G. R. F., Diehl V. Expression of interleukin-2Rα and Interleukin-2Rβ in Hodgkin's disease. Am. J. Pathol. 1993; 142: 1714
   PubMed Web of Science ®Google Scholar
• Miyazaki T., Maruyama M., Yamada G., Hatakeyama M., Tanigushi T. The integrity of the conserved “WS motif” common to IL-2 and other cytokine receptors is essential for ligand binding, and activation of the receptor. EMBO J. 1991; 10: 3191–3197
   PubMed Web of Science ®Google Scholar
• Yoshimura A., Zimmers T., Neumann D., Longmore G., Yoshimura Y., Lodish H. F. Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoetin receptor abolish processing, ligand binding, and activation of the receptor. J. Biol. Chem. 1992; 267: 11619–11625
   PubMed Web of Science ®Google Scholar
• Watowich S., Yoshimura A., Longmore G., Hilton D., Yoshimura Y., Lodish H. F. Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 1992; 89: 2140–2144
   PubMed Web of Science ®Google Scholar
• Durkop H., Latza U., Hummel M., Eitelbach F., Seed B., Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992; 3: 421–427
   Web of Science ®Google Scholar
• Krishnan J., Tomaszewski M. M., Kao G. F. Primary cutaneous CD30-positive anaplastic large cell lymphoma. Report of 27 cases. J. Cutan. Pathol. 1993; 3: 193–202
   Web of Science ®Google Scholar
• Sawyers C. L., Denny C. T. Chronic myelomonocytic leukemia: Tel-a-kinase what ets all about. Cell 1994; 77: 171–173
   PubMed Web of Science ®Google Scholar
• Golub T. R., Baker G. F., Lovett M., Gilliand D. G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t (5; 12) chromosomal translocation. Cell 1994; 77: 307–316
   PubMed Web of Science ®Google Scholar
• Morris S., Kristein M., Valentine M. B., Dittmer K. G., Shapiro D. N., Saltman D. L., Look A. T. Fusion of a kinase gene, ALK, to a nuclear protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284
   PubMed Web of Science ®Google Scholar
• Greco A., Pierotti M. A., Bongarzone I., Pagliardi S., Lanzi C., Delia Porta G. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene 1992; 7: 237–242
   PubMed Web of Science ®Google Scholar
• Kadin M. E., Cavaille-Coll M., Gertz R., Massague J., Cheifetz S., George D. Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc. Natl. Acad. Sci. USA 1994; 91: 6002–6006
   PubMed Web of Science ®Google Scholar
• Waldmann T. A. Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection. Annu. Rev. Immunol. 1992; 10: 675–704
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., White J. D., Goldman C. K., Top L., Grant A., Bamford R., Roessler E., Horak I. D., Zaknoen S., Kasten-Sportes C., England R., Horak E., Mishra B., Dipre M., Hale P., Fleisher T. A., Junghans R. P., Jaffe E. S., Nelson D. L. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood 1993; 82: 1701–1712
   PubMed Web of Science ®Google Scholar